The orphan drug launch, reconsidered

Charlie Gayer, chief commercial officer for BioCryst Pharmaceuticals, talks about how his company, which recently launched an oral medicine into a crowded category, used analytics to rethink the rare-disease drug launch. Check us out at: mmm-online.com

Follow us:

YouTube: @MMM-online

TikTok: @MMMnews

Instagram: @MMMnewsonline

Twitter/X: @MMMnews

LinkedIn: MM+M

To read more of the most timely, balanced and original reporting in
medical marketing, subscribe here.
Music: “Deep Reflection” by DP and Triple Scoop Music.

Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com
for information about our collection and use of personal data for
advertising.